Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry up
Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall...
Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall...
U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week
A tornado has heavily damaged a large Pfizer pharmaceutical plant in North Carolina
Pfizer topped Wall Street expectations even as sales of its top-selling COVID-19 vaccine crumbled in the first quarter
Pfizer will spend about $43 billion to buy Seagen and broaden its reach into cancer treatments, the pharmaceutical giant...
Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to pro...
Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5
Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies
Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales for its coronavirus vac...
Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots